Session Type
Meeting
Search Results for Cancer
Abstract Number: 48
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Triple negative breast cancer (TNBC) comprises of approximately 15% of the total breast cancers. There is limited data on treatment outcome of these patients in elderly population. We report our experience with elderly patients with TNBC treated at our tertiary care center. Methods: With IRB approval, the Cleveland Clinic’s database was used to identify […]
Abstract Number: 63
Hospital Medicine 2020, Virtual Competition
Background: Management of the hospitalized cancer patient represents unique challenges: delivery of complex, specialized medical management to a growing population, compounded by intense scrutiny of patient preference and goals of care. Historically, these patients have been admitted to a subspecialist’s service, but many institutions have now transitioned to a hospitalist-driven care model. Limited research suggests […]
Abstract Number: 77
SHM Converge 2021
Background: Primary Metastatic penile cancer (PMPC) is a rare condition, accounts for less than 1 percent of all men cancers in the United States. This review aims to investigate the clinical characteristics, treatment, and outcomes of Advanced-stage PMPC. Methods: PubMed, Medline, Scopus, and ScienceDirect databases were reviewed for the published case reports on “primary penile […]
Abstract Number: 77
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Disparities in screening mammography use persist among low-income women, even those who are insured, despite the proven mortality benefit. We evaluated the prevalence of breast cancer screening non-adherence among hospitalized women and their receptivity to inpatient screening mammography as a novel approach to increase breast cancer screening rate. Methods: A cross sectional study was […]
Abstract Number: 83
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Approximately 15% of women in the United States aged 35-79 year are at high risk for developing breast cancer, however less than 0.2% of these women reported taking chemoprevention to reduce their risk. Objective of the study was to characterize the current utilization of chemoprevention agents among hospitalized women who are at higher risk […]
Abstract Number: C9
SHM Converge 2022
Background: To evaluate prevalence of non-adherence to breast cancer screening guidelines after bedside educational intervention and informed individualized risk assessment score during an inpatient stay. Methods: A prospective intervention study was conducted among 507 cancer-free (except skin cancer) women aged 50-75 years hospitalized to a general medicine service. Study intervention included one-on-one bedside education via […]
Abstract Number: D9
SHM Converge 2022
Background: Despite the proven mortality benefit of screening colonoscopy, approximately 27% of hospitalized women are non-adherent with colorectal cancer screening guidelines. Colonoscopy is the most frequently used test for colorectal cancer screening in US. Although Medicare and most insurance plans would cover screening colonoscopy, colorectal cancer screening has not been part of usual hospital care. […]
Abstract Number: N2
SHM Converge 2022
Case Presentation: A 45-year-old female with no significant medical history presented to the ED with three days of sharp epigastric pain radiating to the right lower quadrant associated with fever, chills, and multiple episodes of non-bilious, non-bloody emesis. She denied chest pain, shortness of breath, or bruising. Physical examination revealed normal vital signs except a […]
Abstract Number: N8
SHM Converge 2022
Background: In 2020, melanoma exhibited the 5th highest incidence rate of all cancers in the US. While metastatic melanoma constitutes only 4% of new melanoma cases, the 5-year survival rate of metastatic melanoma is 27% [1]. Immune Checkpoint Inhibitors (ICIs) were the first drugs to significantly improve the 5-year survival of late-stage melanoma patients; these […]
Abstract Number: O6
SHM Converge 2022
Background: Increasing evidence points towards incarceration causing poor health, with one study estimating that every year in prison is associated with a two-year reduction in life expectancy (1). Cervical cancer is the most common cancer among incarcerated females (2,3). No study has yet examined whether this increased rate of cervical cancer diagnosis persists after release. […]